MH

Matthew Hobson

Principal at Catalio Capital Management

New York, New York

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Principal

    2023

  • Sr. Analyst

    2020 - 2023

    Sr. Analyst at Catalio Capital Management, a venture capital fund focused on breakthrough biomedical technologies

  • Postdoctoral Researcher

    2020 - 2021

  • PHD Candidate

    2013 - 2020

    PhD candidate in James Berger's lab. I utilize protein engineering and structural methods to investigate type II topoisomerases.

  • Undergraduate Researcher

    2010 - 2013

    Currently synthesizing and characterizing Nucleic Acid orthologs to understand factors effecting duplex thermodynamics and conformation. Worked on characterizing the binding site of the liker domain of the protein VirA of Agrobacterium Tumefaciens via affinity labeling and peptide mapping. VirA is part of the VirA/VirG system which initiates and mediates DNA transformation of plants. This is used a method of genetic modification.

  • Contractor

    2010 - 2012

    Conducting research in the National Institute of Biomedical Imaging and Bioengineering.

  • Intern

    2009 - 2009

    Participated in a DOD sponsored summer internship program. Worked on a malaria vaccine development project characterizing the optimal route of administration via ELISA.